New York University Langone — New York, New York

Public research footprint of New York University Langone, compiled from the ClinicalTrials.gov public registry.

276

Registered studies

Active

Recruiting now

152

Completed

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer, NSCLC · Breast Cancer · Bronchiectasis · KRAS G12C-mutated Solid Tumors, Lung Cancer

Recently updated registry entries

NCT07232069 — PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis (Recruiting)
NCT05627362 — A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With… (Active Not Recruiting)
NCT07227025 — A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at New York University Langone?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.